Antimicrob Agents Chemother. 2013;57:1496–504.PubMedCentralPubMedCrossRef
85. Jacqueline C, Amador G, Caillon J, et al. Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin-resistant Staphylococcus aureus acute osteomyelitis. J Antimicrob Chemother. 2010;65:1749–52.PubMedCrossRef 86. Cottagnoud P, Acosta F, Accosta F, Eggerman U, Biek D, Cottagnoud M. Ceftaroline www.selleckchem.com/products/gdc-0068.html is superior to cefepime against a Klebsiella pneumoniae strain an experimental rabbit meningitis model (Abstract number: P1569). Abstracts 20th European Congress of Clinical Microbiology and Infectious Diseases, Vienna; 2010. 87. Ho TT, Cadena J, Childs LM, Gonzalez-Velez M, Lewis JS 2nd. Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy. J Antimicrob BB-94 Chemother. 2012;67:1267–70.PubMedCrossRef 88. Rose WE, Schulz LT, Andes D, et al. Addition of ceftaroline to daptomycin after emergence of daptomycin-nonsusceptible Staphylococcus aureus Selleck Necrostatin-1 during therapy improves antibacterial activity. Antimicrob Agents Chemother. 2012;56:5296–302.PubMedCentralPubMedCrossRef 89. Werth BJ, Sakoulas G, Rose WE, Pogliano J, Tewhey R, Rybak MJ. Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/pharmacodynamic
model. Antimicrob Agents Chemother. 2013;57:66–73.PubMedCentralPubMedCrossRef 90. Marschall J, Lane MA, Beekmann SE, Polgreen PM, Babcock HM. Current management of prosthetic joint infections in adults: results of an Emerging Infections Network survey. Int J Antimicrob Agents. 2013;41:272–7.PubMedCrossRef 91. Jongsma K, Joson J, Heidari A. Ceftaroline in the treatment of concomitant methicillin-resistant and daptomycin-non-susceptible Staphylococcus aureus infective endocarditis and osteomyelitis: case report. Thiamet G J Antimicrob Chemother. 2013;68:1444–5.PubMedCrossRef 92. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin
SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, M JR, Talan DA, Chambers HF. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52:285–92.”
“Introduction The global health effort to eradicate poliomyelitis (polio) has encountered a number of unforeseen and unpredictable challenges which have been well documented [1]. This article provides a timely review of these challenges and looks toward overcoming the remaining barriers to eradication. Methods The authors undertook a comprehensive literature review using the Internet and the databases JSTOR, PubMed, ScienceDirect and SwetsWise.